NCT00157131已完成3 期
A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 150
- 试验地点
- 17
- 主要终点
- Adverse experiences (AEs) deemed possibly or probably related to treatment with FS 4IU VH S/D
研究概览
简要总结
The primary objective of this study is to evaluate skin graft adherence and wound healing in burn patients to evaluate whether FS 4IU VH S/D is equivalent or superior to the current standard of care (staples). The primary endpoint is achievement of complete (100%) wound closure within 28 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- — 至 65 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects or their legal representatives, who have read, understood and signed a written informed consent.
- •Subjects of either sex.
- •Female subjects of childbearing potential with a negative urine or serum pregnancy test on admission.
- •Subjects who are <= 65 years of age including pediatric subjects of all ages.
- •Subjects with total burn wounds measuring <= 40% TBSA.
- •Subjects with a contiguous deep partial thickness/full thickness wound, between 2% and 8% TBSA or two comparable, bilateral wounds each measuring between 1% and 4% TBSA.
- •Wounds designated as test sites require autologous sheet skin grafts with a thickness of 8/1000" - 16/1000"
- •Subjects who are able, and willing to comply with the procedures required by the protocol.
排除标准
- •Subjects with electrical burns.
- •Subjects with chemical burns
- •Digits and genitalia are excluded as test sites.
- •Subjects with infection at test area/test sites.
- •Subjects with test sites previously randomized and treated in this study.
- •Subjects with venous or arterial vascular disorder that directly affects a designated test area/test site.
- •Subjects with pre-existing hemolytic anemia
- •Subjects with diabetes mellitus.
- •Subjects with documented history of pathologically or pharmacologically induced immune deficiency.
- •Subjects judged to be chronically malnourished.
- •Subjects that are judged to have significant pulmonary compromise.
- •Subjects receiving systemic corticosteroids within 30 days prior to skin grafting (not including inhaled steroids).
- •Subjects with known or suspected hypersensitivity to bovine proteins.
- •Subjects participating in another clinical trial that is evaluating an unapproved drug or device.
结局指标
主要结局
Adverse experiences (AEs) deemed possibly or probably related to treatment with FS 4IU VH S/D
时间窗: 12 months after treatment
Complete wound closure by Day 28 after treatment with either FS 4IU VH S/D or staples as determined by a blinded independent review of the Day 28 photographs
时间窗: 28 days after treatment
次要结局
- Presence of hematoma/seroma on Day 1(1 day after treatment)
- Percent area of hematoma/seroma on Day 1(1 day after treatment)
- 100% engraftment by Day 5(5 days after treatment)
- Percent area of engraftment on Day 5(5 days after treatment)
- Complete wound closure by Day 14(14 days after treatment)
- Scar maturation assessed by blinded Vancouver Scar Scale evaluations on Months 3, 6, 9, and 12(3, 6, 9, and 12 months after treatment)
- Percent area of closure by Days 14 and 28(14 and 28 days after treatment)
研究者
研究点 (17)
Loading locations...
相似试验
已完成
不适用
Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic AcidSkin FoldsWrinkleNCT05450380Mesoestetic Pharma Group S.L.50
终止
不适用
Epidermal Coverage of Traumatic Wound Injuries Via Use of Autologous Spray Skin Applied Over Bilayered Wound MatrixWounds and InjuryNCT02469168Rubin, J. Peter, MD1
已完成
1 期
Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn WoundsBurnsNCT00161759Baxter Healthcare Corporation40
已完成
4 期
Effect of Fibrin Sealant on Early Wound HealingPeriodontitisNCT01538927Chhattisgarh Dental College and Research Institute15
已完成
不适用
Wound Repair and Body Contouring Surgery After Gastric BypassObesity, MorbidNCT00609037Vanderbilt University34
